Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 29, 2017

DrugPatentWatch Database Preview

PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE Drug Profile

« Back to Dashboard

What is the patent landscape for Pseudoephedrine Hydrochloride And Chlorpheniramine Maleate, and when can generics launch?

Pseudoephedrine Hydrochloride And Chlorpheniramine Maleate is a drug marketed by Cent Pharms, Graham Dm, and Kv Pharm. and is included in four NDAs.

The generic ingredient in PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE is chlorpheniramine maleate; pseudoephedrine hydrochloride. There are twenty-nine drug master file entries for this compound. Additional details are available on the chlorpheniramine maleate; pseudoephedrine hydrochloride profile page.

Summary for Tradename: PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE

Patents:0
Applicants:3
NDAs:4
Clinical Trials: see list39,579
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cent Pharms
PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate; pseudoephedrine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL019428-001Aug 2, 1988DISCNNoNo► Subscribe► Subscribe
Kv Pharm
PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate; pseudoephedrine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL071455-001Mar 1, 1989DISCNNoNo► Subscribe► Subscribe
Graham Dm
PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate; pseudoephedrine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL018843-001Mar 18, 1985DISCNNoNo► Subscribe► Subscribe
Graham Dm
PSEUDOEPHEDRINE HYDROCHLORIDE AND CHLORPHENIRAMINE MALEATE
chlorpheniramine maleate; pseudoephedrine hydrochloride
CAPSULE, EXTENDED RELEASE;ORAL018844-001Mar 20, 1985DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Uncover prior art in abandoned patent applications and expired patents
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot